No Detail Found!

Fibrinogen titer and glycemic status in women using contraceptives

Author(s)
SadiqaSyed Department of Physiology, Fatima Jinnah Dental College, Karachi. Pakistan
MasoodA. Qureshi Department of Physiology, Molecular and Clinical Endocrinology Unit, University of Karachi, Pakistan.
Abstract
To assess the coagulation and glycemic status in Pakistani women using contraceptives. Design : The study was conducted prospectively on 70 women and compared with 10 age-matched controls. Place and Duration of Study: The study was conducted at Karachi. Period of study was 18 month. Subjects and Methods: Eighty women aged between 20-45 years selected from low socioeconomic class and poor family background were categorized in control (n=10) and oral and injectable contraceptive users (n=70). The contraceptives used were tablet Lofemenal, injection Norigest and Norplant implant. Their blood was tested for fibrinogen titer and random blood glucose. Results: There was no appreciable difference either in fibrinogen titer or plasma glucose levels in injectable users as compared to controls, but increased incidence of high fibrinogen titer and borderline blood glucose was observed in oral contraceptive users 25% and 20% respectively. Conclusion: It was concluded that long-term use of oral contraceptives (> 3 years) might increase the thrombotic tendency and elevate the plasma glucose levels especially in women above 30 years of age. .
Publication Details
Page(s) 16-22
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 12, Issue: 1, Year: 2002

Request the full text from PASTIC

Keywords
contraceptives, Fibrinogen, Oral, Bloood Glucose
References
.1998 .. Contraceptitveechnology. 17threv.ed.NewYorkA.rdentMedia, : 13-42.
Ara Jahan .1994 .Population controla:n unsolved proble min PakistanS. , 10 : 369-72.
PopulationReferenceBureau .1999 .Worldpopulation datasheet(WallChart). , : .
. .. JFam. P/ann2MXy, 26 : 10-11.
Guest F . .. NewYork: ArdentMedia1998, : 405-66.
Lewis MA,SpitzerWO. MA .1996 .The increasedriskofvenousthromboe­m bolismandtheuseofthirdgeneratiopnrogestogens: roleof biasin observatiornesearchCo. ntraception, 54 : 5-13.
.1999 .­ep tivesand high factorV111 levelsT. hromb Haemost, 82 : 1024-7.
. .. Effectsof oralcontraceptivoenscarbohydratmeetabolis mJ'R.eprod'Med1986; 31 (suppl.3), : 892-7.
.1990 .Clinicalaspectsof the relationshbipetweenoralcontraceptiveasb,norma­li tiesin carbohydramteetabolisamndthedevelopment of cardiovasculdaisrease. Am J Obstet Gynecol, 163 : 334-43.
Cerel-SuhlSL .1999 .YeagerBE Updateoralcontraceptive29. mFamPhysician, 60 : 2073-84.
Chasan-TabeLr ,Spiegelman D .1996 .Prospectivsetudyof oral contraceptivaensdhypertensioanmongwomenin the UnitedStatesC. , 94 : 483-9.
.1997 .CalhounDA, OparilS. High bloodpressurien women. intJFertiiWomens Med, 42 : 198-205.
.1975 .. aris:L'Expansion Scientifique, : .
.2000 .Evaluationof metaboliccontroinl diabetes. Priciplesof endocrinology and metabolismP.hiladelphia.Lippincot Williams and Wilkins, : 1336-40.
Shamim N .1994 .. Use of norplanitn Pakistant:woyearsexperienceJ.PMA, 44 : 3-7.
.1996 .A comparativsetudyof theeffectson the hemostatic 38. JacksonWE. Oralcontraceptivaensdrenalandretinal tivescontaining20pg and 30pg ethinylestradiol. complicatioinnsyoungwomenwithinsulindependent Contraception, 53 : 1099-1102.
0

Citations

0

Downloads

136

Views